At the end of the article, there is a link to a talk given by the author Dr. Farhad Dalal in 2015 (it's not given a hyperlink on the Mad in...
Like most of you I have struggled with terminology & language used. However I did find this via Self Hacked (admittedly not always the most...
Interesting list of authors... Anybody know more about Gerwyn Morris or Michael Maes? On some of the quoted papers Morris is listed as a...
Also selection criteria for ME/CFS are not discussed anywhere nor the magic phrase PEM. As a side note, I'veI've across quite a few people in my...
The limitations section after the Discussion is worth noting. Throughout the paper "heterogeneous" crops up a lot. :) Limitations Evidence for...
Full paper is available via Sci Hub https://sci-hub.tw/10.2217/epi-2017-0150
*I understand that Sharpe (& Wessely) have set up Google alerts relating to their work, which is maybe why they are quick to respond on subjects...
Wonder if Michael Sharpe will threaten the solicitors with libel?
PS Mark Guthridge is definitely worth following on Twitter. He seems a knowledgeable communicative guy.
[MEDIA]
Dr Mark Guthridge of Monash University in Melbourne has given his thoughts on the possible use and results of giving Metformin to ME/CFS patients...
Prof Michael Sharpe's Oxford home & choice of venue for "special ethics" lectures. [MEDIA]
Enter James Coyne stage left [MEDIA]
Michael Sharpe latest [ATTACH]
Like @Trish, I've been trying to understand AMPK signalling without causing instant brain fog. Found this video on YouTube, which has enlightened...
My favourite from MS's output today.... Nasty allegation. Your analysis is invalid. Sorry [MEDIA]
From the discussion "The important findings from this study are that, firstly, pharmacological activation of AMPK can improve glucose uptake in...
How the study was funded "Acknowledgements The work was funded by ME Research UK and supported by the NIHR Newcastle Clinical Research Facility."
There's always a race to say this. ;)
There's also a thread from AndyPandy who talks about their experiences withMetformin as a type 2 diabetic. They may be very different from people...
Separate names with a comma.